Last Price | 63.00 | Max Price | 79.70 |
Min Price | 60.40 | 1 Year return | 2.94 |
Sector | Health Care | Subsector | Pharmaceuticals |
Annual report 2014 |
Contact info:Street: Via C. Colombo 1Zip Code: 20020Postbox: 20020City: LainateCountry: ItalyPhone: +39 02 9333 7614Email: info@cosmopharmaceuticals.comWebsite: www.cosmoarmaceuicals.comCEO: Alessandro Della ChàCFO: Hans Christoph Tanner
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 63 | 615,670 | 0.01 % |
2020 | 61 | 638,104 | 0.01 % |
2021 | 65 | 727,997 | 0.01 % |
2022 | 102 | 787,317 | 0.01 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
The period between December 2015 and December 2016 was a good period for the investors. The stock gained almost 7 percent. Over the period 2011-2016 the stock rose a massive 900 percent. Cosmo Pharmaceuticals's revenues between 2011 and 2015 were very fluctuating and moved between 33,51 million euros and 79,59 million euros. Cosmo Pharmaceuticals's net results between 2011 and 2015 were quite unstable and moved between 3,61 million euros and 73,32 million euros.
The company's head quarter is located in Lainate. The global pharmaceutical companies gained around 75 percent worldwide over the last 10 years. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.
The Italian company paid out dividends in the past 5 years. On average the Cosmo Pharmaceuticals stock yielded a delivered a dividend yield of around 2,4 percent over the past 5 years. Over the past 5 years Cosmo Pharmaceuticals raised her dividends share each year. Based on the yearly higher dividend payments Cosmo Pharmaceuticals is a kind of dividend aristocrat.
At the end of 2015 the Italian company had a balance sheet of 225,62 million euros. 73,34 million euros (32,51 percent of the total balance sheet) was financed by debt. The Italian company's price/earnings-ratio was 34. So the market valued the stock at 34 times the 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the Italian stock can be seen as a growth stock.
At the end of 2015 the Italian company's market capitalization equaled around 2,33 billion euros. At the end of 2015 the Italian company had around 14,33 million stocks listed on the exchanges.
All the annual reports of Cosmo Pharmaceuticals are available here. More information about Cosmo Pharmaceuticals can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
61
|
68
|
67
|
66
|
63
|
61
|
Costs |
-188
|
51
|
100
|
84
|
87
|
69
|
Profit |
248
|
17
|
-32
|
-18
|
-24
|
-8
|
Margin of profit |
409.49
|
24.84
|
-48.26
|
-27.45
|
-39.07
|
-12.96
|
ROI |
61.49
|
4.05
|
-6.90
|
-4.06
|
-6.20
|
-1.97
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
404
|
416
|
470
|
444
|
394
|
400
|
Debt |
34
|
28
|
28
|
182
|
191
|
196
|
Total assets |
438
|
443
|
498
|
626
|
585
|
596
|
Solvency |
92.17
|
93.70
|
94.41
|
70.92
|
67.29
|
67.12
|
Cash |
116
|
166
|
173
|
349
|
268
|
213
|
Cashflow |
-39
|
22
|
-9
|
-10
|
-19
|
13
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
-1.14
|
0.78
|
-0.34
|
-0.06
|
-0.10
|
0.07
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
162.20
|
169.30
|
146.40
|
87.90
|
76.70
|
Eps |
1.17
|
-2.19
|
-1.20
|
-1.67
|
-0.55
|
Price/earnings-ratio |
138.63
|
-77.31
|
-122.00
|
-52.63
|
-114.55
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
29.46
|
31.26
|
29.91
|
27.12
|
27.72
|
Market to book |
0.18
|
0.18
|
0.20
|
0.31
|
0.44
|
Cashflow per stock |
1.54
|
-0.63
|
-0.68
|
-1.30
|
0.90
|
Stocks |
14
|
15
|
15
|
15
|
14
|
Market Cap |
2.287.59
|
2.545.85
|
2.171.95
|
1.275.93
|
909.30
|
Date
|
Price
|
---|---|
07 Feb 2025
|
63.00
|
05 Feb 2025
|
62.80
|
02 Feb 2025
|
65.90
|
21 Jan 2025
|
64.60
|
17 Jan 2025
|
64.40
|
09 Jan 2025
|
64.70
|
17 Dec 2024
|
60.40
|
10 Dec 2024
|
60.70
|
06 Dec 2024
|
61.40
|
03 Dec 2024
|
62.00
|
29 Nov 2024
|
62.90
|
27 Nov 2024
|
62.70
|
13 Nov 2024
|
64.00
|
08 Nov 2024
|
65.20
|
05 Nov 2024
|
66.80
|
31 Oct 2024
|
68.20
|
29 Oct 2024
|
69.80
|
23 Oct 2024
|
72.20
|
19 Oct 2024
|
73.70
|
16 Oct 2024
|
74.70
|
14 Oct 2024
|
74.50
|
05 Oct 2024
|
75.60
|
02 Oct 2024
|
74.90
|
27 Sep 2024
|
76.80
|
20 Sep 2024
|
78.30
|
17 Sep 2024
|
78.20
|
13 Sep 2024
|
79.30
|
28 Aug 2024
|
79.30
|
26 Aug 2024
|
78.60
|
23 Aug 2024
|
79.70
|